Expression of a RAS Degrader via Synthetic Nanocarrier-Mediated mRNA Delivery Reduces Pancreatic Tumors
ACS Applied Bio Materials · 2025
DOI: 10.1021/acsabm.5c00179 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Bio Materials, 2025. Verfasst von Taylor E Escher und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology-Immunology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois 60611, United States. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, RNA, Messenger, Biocompatible Materials, ras Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: National Cancer Institute, Chicago Biomedical Consortium, Office of Science.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology-Immunology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois 60611, United States.
- Department of Biomedical Engineering, Northwestern University, Evanston, Illinois 60208, United States.
- Department of Obstetrics and Gynecology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois 60611, United States.
- Chemistry of Life Processes Institute, Northwestern University, Evanston, Illinois 60208, United States.
- Robert H. Lurie Comprehensive Cancer Research Center, Northwestern University, Feinberg School of Medicine, Chicago, Illinois 60611, United States.
- Bioengineering Institute, King Abdulaziz City for Science and Technology, Riyadh 11442, Saudi Arabia.
ORCID-Profile: Evan A Scott, Karla J F Satchell
Förderung
- National Cancer Institute
- Chicago Biomedical Consortium
- Office of Science
- Horizon 2020 Framework Programme
- National Science Foundation
- SQI Synthesizer Grant Program
Zitieren
APA
Escher, T. E., Yuk, S. A., Qian, Y., Qiang, W., Almunif, S., Sharma, S., Scott, E. A., & Satchell, K. J. F. (2025). Expression of a RAS Degrader via Synthetic Nanocarrier-Mediated mRNA Delivery Reduces Pancreatic Tumors. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.5c00179
Vancouver
Escher TE, Yuk SA, Qian Y, Qiang W, Almunif S, Sharma S, et al. Expression of a RAS Degrader via Synthetic Nanocarrier-Mediated mRNA Delivery Reduces Pancreatic Tumors. ACS Applied Bio Materials. 2025. doi:10.1021/acsabm.5c00179
BibTeX
@article{Escher2025,
author = {Escher, Taylor E and Yuk, Simseok A and Qian, Yuan and Qiang, Wenan and Almunif, Sultan and Sharma, Swagat and Scott, Evan A and Satchell, Karla J F},
title = {Expression of a RAS Degrader via Synthetic Nanocarrier-Mediated mRNA Delivery Reduces Pancreatic Tumors},
journal = {ACS Applied Bio Materials},
year = {2025},
doi = {10.1021/acsabm.5c00179}
}
EUVIMED